ACRS icon

Aclaris Therapeutics
ACRS

Overview Fund Activity

127 hedge funds and large institutions have $957M invested in Aclaris Therapeutics in 2022 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 48 increasing their positions, 26 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
127
Holders Change
+12
Holders Change %
+10.43%
% of All Funds
2.2%
Holding in Top 10
9
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
19
Increased
48
Reduced
26
Closed
6
Calls
$362K
Puts
$357K
Net Calls
+$5K
Net Calls Change
-$250K

Top Buyers

1
Walleye Capital
1
Walleye Capital
New York
$4.25M
2
Charles Schwab
2
Charles Schwab
California
$6.34M
3
Citadel Advisors
3
Citadel Advisors
Florida
$17.6M
4
BlackRock
4
BlackRock
New York
$75.7M
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$29.2M

Top Sellers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$54.4M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$18.7M
3
LCM
3
Laurion Capital Management
New York
$20.5M
4
Assenagon Asset Management
4
Assenagon Asset Management
Luxembourg
$3.07M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$18M
Name Holding Trade Value Shares
Change 		Shares
Change %
ACM
26
Aisling Capital Management
New York
$9.99M – – –
Northern Trust
27
Northern Trust
Illinois
$8.71M +$469K +29,805 +6%
SCM
28
Silverarc Capital Management
Massachusetts
$8.56M +$66.6K +4,231 +0.8%
JPMorgan Chase & Co
29
JPMorgan Chase & Co
New York
$7.13M -$136K -8,631 -2%
Goldman Sachs
30
Goldman Sachs
New York
$6.65M +$226K +14,358 +4%
FLSM
31
Frazier Life Sciences Management
California
$6.43M – – –
Charles Schwab
32
Charles Schwab
California
$6.34M +$3.91M +248,235 +161%
SSA
33
Schonfeld Strategic Advisors
New York
$6.3M -$568K -36,100 -8%
Verition Fund Management
34
Verition Fund Management
Connecticut
$5.86M +$596K +37,841 +11%
PA
35
Perceptive Advisors
New York
$5.37M – – –
IHAM
36
Integral Health Asset Management
New York
$5.35M +$850K +54,029 +19%
Walleye Capital
37
Walleye Capital
New York
$4.25M +$4.25M +269,948 New
Bank of New York Mellon
38
Bank of New York Mellon
New York
$3.68M +$499K +31,683 +16%
PHP
39
Parkman Healthcare Partners
Connecticut
$3.68M -$1.12M -71,217 -23%
Nuveen Asset Management
40
Nuveen Asset Management
Illinois
$3.49M -$461K -29,290 -12%
HS
41
HighVista Strategies
Massachusetts
$3.43M +$4.56K +290 +0.1%
Millennium Management
42
Millennium Management
New York
$3.21M +$80.4K +5,111 +3%
Assenagon Asset Management
43
Assenagon Asset Management
Luxembourg
$3.07M -$1.54M -98,122 -33%
Morgan Stanley
44
Morgan Stanley
New York
$2.64M +$105K +6,702 +4%
ACP
45
Acuta Capital Partners
California
$2.53M -$504K -32,000 -17%
AAA
46
Affinity Asset Advisors
New York
$2.15M +$573K +36,434 +36%
UOC
47
UBS O'Connor
Illinois
$1.79M – – –
Swiss National Bank
48
Swiss National Bank
Switzerland
$1.74M +$150K +9,500 +9%
VOYA Investment Management
49
VOYA Investment Management
Georgia
$1.68M +$1.33M +84,287 +375%
Balyasny Asset Management
50
Balyasny Asset Management
Illinois
$1.67M +$1.67M +106,147 New
1
2
3 4 5